GLENVIEW CAPITAL MANAGEMENT, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001138995

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHigh Turnover how tags are computed

Q2 2025 · 43 positions · Total reported value $3.57B · Top-10 concentration 68.3% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 69.6% · 13 new · 14 cut · 12 exited

Active Share (vs S&P 500): 87.0% · vs QQQ: 87.1% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +32.1% · vs SPY +17.3% · Prev Value $3.56B — last quarter positions weighted by this quarter price moves · ranking

In its Q2 2025 13F filing, GLENVIEW CAPITAL MANAGEMENT, LLC disclosed 43 equity positions with a combined reported value of $3.57B. The filing implies a focused portfolio: its ten largest positions account for 68.3% of reported value. HoldingsHub classifies the profile as Mid / Focused / High Turnover.

The largest disclosed positions as of Q2 2025 were CVS ($565.42M), THC ($515.68M), GPN ($345.52M). By sector, the heaviest allocations are Health Care 34.2%, Consumer Discretionary 28.3%. Versus the prior quarter, allocation shifted toward Technology (+2.7pp), Industrials (+2.5pp) and away from Other (-2.2pp), Consumer Staples (-6.7pp).

Versus the prior quarter, GLENVIEW CAPITAL MANAGEMENT, LLC opened 13 new positions, trimmed 14 and fully exited 12, a turnover rate of 69.6% of positions. The portfolio's overlap with the prior quarter was 61% of names.

The largest new positions opened in Q2 2025 were DKS ($57.47M), TMO ($40.55M), SGRY ($33.99M).

Of the 12 positions fully exited versus the prior quarter, the largest were CTVA ($87.61M), DNB ($87.33M), CNC ($79.02M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2025)

  • DKS DICKS SPORTING GOODS INC · $57.47M
  • TMO THERMO FISHER SCIENTIFIC INC · $40.55M
  • SGRY SURGERY PARTNERS INC COM · $33.99M
  • MKSI MKS INC. · $23.08M
  • COO COOPER COS INC · $19.97M
  • EYE NATIONAL VISION HLDGS INC · $18.70M
  • IQV IQVIA HLDGS INC · $15.76M
  • RH RH · $12.46M

Fully Exited (vs previous quarter)

  • CTVA CORTEVA INC · prev qtr: $87.61M
  • DNB DUN & BRADSTREET HLDGS INC · prev qtr: $87.33M
  • CNC CENTENE CORP DEL · prev qtr: $79.02M · history
  • DIS DISNEY WALT CO · prev qtr: $36.29M
  • PINS PINTEREST INC · prev qtr: $32.97M
  • DKNG DRAFTKINGS INC NEW · prev qtr: $15.62M
  • XRAY DENTSPLY SIRONA INC · prev qtr: $12.78M
  • OSCR OSCAR HEALTH INC · prev qtr: $10.47M

Insider Transactions (Form 4)

Latest GLENVIEW CAPITAL MANAGEMENT, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Glenview Capital Management is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 44 US equity positions with a combined value of $5.23B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-73695 (status: Approved), registered 2012-03-30
  • Regulatory AUM (Form ADV): $6.37B as of 2026-09-15
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 6 private funds, of which 6 hedge funds

Portfolio Structure

  • 44 positions · $5.23B reported value (Q2 2026)
  • Top 10 holdings = 62.0% of reported value
  • Largest position: GPN (GLOBAL PMTS INC) at 12.4%
  • Average position size: $118.86M

Sector Tilt

  • Health Care 28.5%
  • Consumer Discretionary 26.6%
  • Industrials 14.0%
  • (classified holdings cover 91% of value)

Quarterly Activity

  • Q2 2026: 13 new, 14 added, 14 reduced, 12 exited
  • 3 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 34.2%
Technology 12.4%
Other 0.0%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 8.20M $565.42M 15.84%
15.84%
Reduce
2 2.93M $515.68M 14.45%
14.45%
Reduce
3 4.32M $345.52M 9.68%
9.68%
Add
4 15.82M $265.21M 7.43%
7.43%
Add
5 16.38M $165.78M 4.64%
4.64%
Add
6 24.38M $138.00M 3.87%
3.87%
Reduce
7 562.87K $123.49M 3.46%
3.46%
Reduce
8 371.89K $122.94M 3.44%
3.44%
Reduce
9 1.38M $106.19M 2.98%
2.98%
Reduce
10 5.87M $89.70M 2.51%
2.51%
Reduce
11 508.26K $85.73M 2.40%
2.40%
Reduce
12 115.93K $85.57M 2.40%
2.40%
Add
13 1.01M $74.78M 2.10%
2.10%
Reduce
14 8.25M $73.65M 2.06%
2.06%
Reduce
15 389.48K $70.55M 1.98%
1.98%
Reduce
16 2.82M $63.78M 1.79%
1.79%
Add
17 290.53K $57.47M 1.61%
1.61%
New
18 1.17M $51.74M 1.45%
1.45%
Reduce
19 270.00K $45.64M 1.28%
1.28%
Add
20 568.86K $45.30M 1.27%
1.27%
Add
21 100.00K $40.55M 1.14%
1.14%
New
22 600.57K $38.43M 1.08%
1.08%
Reduce
23 658.50K $36.38M 1.02%
1.02%
Reduce
24 1.53M $33.99M 0.95%
0.95%
New
25 407.01K $31.50M 0.88%
0.88%
Add
26 241.39K $29.03M 0.81%
0.81%
Add
27 527.89K $27.00M 0.76%
0.76%
Add
28 266.67K $24.88M 0.70%
0.70%
Reduce
29 4.59M $24.36M 0.68%
0.68%
Add
30 232.30K $23.08M 0.65%
0.65%
New
31 4.76M $20.46M 0.57%
0.57%
Reduce
32 1.55M $20.22M 0.57%
0.57%
Add
33 280.69K $19.97M 0.56%
0.56%
New
34 9.96M $19.91M 0.56%
0.56%
Hold
35 25.58K $18.75M 0.53%
0.53%
Reduce
36 812.53K $18.70M 0.52%
0.52%
New
37 100.00K $15.76M 0.44%
0.44%
New
38 65.92K $12.46M 0.35%
0.35%
New
39 50.00K $9.88M 0.28%
0.28%
New
40 174.19K $9.13M 0.26%
0.26%
New
41 149.38K $1.68M 0.05%
0.05%
Reduce
42 26.03K $1.18M 0.03%
0.03%
Reduce
43 1.71M $103.31K 0.00%
0.00%
Hold

FAQ

What did GLENVIEW CAPITAL MANAGEMENT, LLC buy in 2025-Q2?

In its 2025-Q2 13F filing, GLENVIEW CAPITAL MANAGEMENT, LLC reported 43 equity positions worth $3.57B in aggregate; its largest disclosed positions were CVS ($565.42M), THC ($515.68M), GPN ($345.52M).

How large is GLENVIEW CAPITAL MANAGEMENT, LLC's portfolio?

GLENVIEW CAPITAL MANAGEMENT, LLC reported $3.57B of long equity holdings across 43 positions as of 2025-Q2. Top-10 holdings account for 68.3% of reported value.

What is GLENVIEW CAPITAL MANAGEMENT, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/glenview-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →